Feed ANRO
AN

Alto Neuroscience, Inc. ANRO · NYSE

$22.85 +4.12% (+$0.91)

Market cap
$896.5M
Enterprise value
$659.8M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
18.4%
Gross margin
-
Net margin
-
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
1.16
Free float
90.6%

About the company

ANRO is a Czech company founded in 1993, specializing in the production and sale of a wide range of building materials, particularly insulation and waterproofing systems. ANRO focuses on innovative technologies that improve energy efficiency and extend the lifespan of buildings. The company holds a strong position in the Czech market and also operates in several other European markets, where it has built a reputation as a high-quality and reliable supplier of construction materials.

Sector

Healthcare

Industry

Biotechnology

CEO

Amit Etkin

Employees

68

Headquarters

Mountain View

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.